Sichenzia Ross Ference LLP Represents Aegis Capital in $16.0 Million Initial Public Offering of Inspira Technologies OXY B.H.N. Ltd

Press Release – New York, NY – July 19, 2021 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the initial public offering of 2,909,091 units of Inspira Technologies OXY B.H.N. Ltd (the Company), an Israeli specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology. The offering was priced at $5.51 per unit, each consisting of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $5.50 per share. The ordinary shares and warrants are trading on NASDAQ under the symbols “IINN” and “IINNW”, respectively.

In addition, the Company granted Aegis Capital Corp. a 45-day option to purchase up to 436,363 additional ordinary shares and/or 436,363 warrants to purchase 436,363 ordinary shares at the public offering price to cover over-allotments. The underwriter partially exercised its over-allotment option with respect to 436,363 warrants to purchase ordinary shares.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, Avital Perlman and Jeffrey Cahlon.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $6.87 Million Public Offering of Common Stock of Twin Vee PowerCats Co. - October 4, 2022
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc. - October 1, 2022
Mid-Level Corporate Associate - September 29, 2022

Sichenzia Ross Ference LLP Represents Aegis Capital in $16.0 Million Initial Public Offering of Inspira Technologies OXY B.H.N. Ltd

Related Posts